1. Home
  2. RDHL vs SLE Comparison

RDHL vs SLE Comparison

Compare RDHL & SLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • SLE
  • Stock Information
  • Founded
  • RDHL 2009
  • SLE 2014
  • Country
  • RDHL Israel
  • SLE United States
  • Employees
  • RDHL N/A
  • SLE N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • SLE Services-Misc. Amusement & Recreation
  • Sector
  • RDHL Health Care
  • SLE Consumer Discretionary
  • Exchange
  • RDHL Nasdaq
  • SLE Nasdaq
  • Market Cap
  • RDHL 8.2M
  • SLE 8.6M
  • IPO Year
  • RDHL N/A
  • SLE 2019
  • Fundamental
  • Price
  • RDHL $5.90
  • SLE $0.54
  • Analyst Decision
  • RDHL
  • SLE Strong Buy
  • Analyst Count
  • RDHL 0
  • SLE 2
  • Target Price
  • RDHL N/A
  • SLE $2.50
  • AVG Volume (30 Days)
  • RDHL 11.1K
  • SLE 71.7K
  • Earning Date
  • RDHL 08-29-2024
  • SLE 03-26-2025
  • Dividend Yield
  • RDHL N/A
  • SLE N/A
  • EPS Growth
  • RDHL N/A
  • SLE N/A
  • EPS
  • RDHL N/A
  • SLE N/A
  • Revenue
  • RDHL $3,707,000.00
  • SLE $22,266,000.00
  • Revenue This Year
  • RDHL $224.90
  • SLE N/A
  • Revenue Next Year
  • RDHL $82.69
  • SLE $33.97
  • P/E Ratio
  • RDHL N/A
  • SLE N/A
  • Revenue Growth
  • RDHL N/A
  • SLE N/A
  • 52 Week Low
  • RDHL $5.41
  • SLE $0.50
  • 52 Week High
  • RDHL $20.28
  • SLE $2.84
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 39.54
  • SLE 44.77
  • Support Level
  • RDHL $5.76
  • SLE $0.57
  • Resistance Level
  • RDHL $6.26
  • SLE $0.65
  • Average True Range (ATR)
  • RDHL 0.32
  • SLE 0.06
  • MACD
  • RDHL 0.01
  • SLE -0.00
  • Stochastic Oscillator
  • RDHL 18.85
  • SLE 53.13

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About SLE Super League Enterprise Inc.

Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn and create. The company offers a complete range of development, distribution, monetization and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising including immersive game world and experience publishing and in-game media products, direct to consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.

Share on Social Networks: